Hydroxysafflor yellow A of Carthamus tinctorius attenuates lung injury of aged rats exposed to gasoline engine exhaust by down-regulating platelet activation
Copyright © 2013 Elsevier GmbH. All rights reserved..
Long-term inhalation of gasoline engine exhaust (GEE) increases the risk of respiratory disease. Studies have suggested involvement of platelets in the development of some lung diseases. Hydroxysafflor yellow A (HSYA), a flavonoid compound, prevents hemostasis. Therefore, we investigated its effects on GEE-induced lung injury, and role of platelets in injury. Sixty-week-old male Sprague-Dawley rats were exposed to GEE for 4h/day for 6 weeks, and then grouped as follows: control, GEE, GEE+HSYA, GEE+HSYA+GW9662, and GEE+GW9662. Arterial oxygen tension (PaO2), carbon dioxide tension (PaCO2), pH, and the PaO2/fraction of inspired oxygen ratio (PaO2/FiO2) in the blood were detected using a blood gas analyzer. Wet/dry lung weight ratio, total protein in bronchoalveolar lavage fluid (BALF), and cytokine concentrations in serum and BALF were determined. Furthermore, cyclic adenosine monophosphate (cAMP) level and expression levels of target proteins were analyzed. Platelets were counted and their state was evaluated. HSYA attenuated GEE-mediated decreases in PaO2, PaO2/FiO2, platelet cAMP level, protein kinase A (PKA) activity, and peroxisome proliferator-activated receptor γ (PPARγ) expression. HSYA also attenuated GEE-mediated increases in lung permeability, cytokine levels in serum and BALF, plasma platelet count, and ADP-mediated platelet aggregation. Moreover, it suppressed GEE-induced increases in the expression of adhesion molecules and proinflammatory cytokines in platelets and lung tissue. Therefore, HSYA is therapeutically effective for GEE-mediated lung injury and acts by enhancing PKA activity and inhibiting platelet activation.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2014 |
---|---|
Erschienen: |
2014 |
Enthalten in: |
Zur Gesamtaufnahme - volume:21 |
---|---|
Enthalten in: |
Phytomedicine : international journal of phytotherapy and phytopharmacology - 21(2014), 3 vom: 15. Feb., Seite 199-206 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Wang, Chaoyun [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 25.11.2014 Date Revised 24.03.2014 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.phymed.2013.09.018 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM232303282 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM232303282 | ||
003 | DE-627 | ||
005 | 20231224092708.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231224s2014 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.phymed.2013.09.018 |2 doi | |
028 | 5 | 2 | |a pubmed24n0774.xml |
035 | |a (DE-627)NLM232303282 | ||
035 | |a (NLM)24192212 | ||
035 | |a (PII)S0944-7113(13)00405-4 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Wang, Chaoyun |e verfasserin |4 aut | |
245 | 1 | 0 | |a Hydroxysafflor yellow A of Carthamus tinctorius attenuates lung injury of aged rats exposed to gasoline engine exhaust by down-regulating platelet activation |
264 | 1 | |c 2014 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 25.11.2014 | ||
500 | |a Date Revised 24.03.2014 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2013 Elsevier GmbH. All rights reserved. | ||
520 | |a Long-term inhalation of gasoline engine exhaust (GEE) increases the risk of respiratory disease. Studies have suggested involvement of platelets in the development of some lung diseases. Hydroxysafflor yellow A (HSYA), a flavonoid compound, prevents hemostasis. Therefore, we investigated its effects on GEE-induced lung injury, and role of platelets in injury. Sixty-week-old male Sprague-Dawley rats were exposed to GEE for 4h/day for 6 weeks, and then grouped as follows: control, GEE, GEE+HSYA, GEE+HSYA+GW9662, and GEE+GW9662. Arterial oxygen tension (PaO2), carbon dioxide tension (PaCO2), pH, and the PaO2/fraction of inspired oxygen ratio (PaO2/FiO2) in the blood were detected using a blood gas analyzer. Wet/dry lung weight ratio, total protein in bronchoalveolar lavage fluid (BALF), and cytokine concentrations in serum and BALF were determined. Furthermore, cyclic adenosine monophosphate (cAMP) level and expression levels of target proteins were analyzed. Platelets were counted and their state was evaluated. HSYA attenuated GEE-mediated decreases in PaO2, PaO2/FiO2, platelet cAMP level, protein kinase A (PKA) activity, and peroxisome proliferator-activated receptor γ (PPARγ) expression. HSYA also attenuated GEE-mediated increases in lung permeability, cytokine levels in serum and BALF, plasma platelet count, and ADP-mediated platelet aggregation. Moreover, it suppressed GEE-induced increases in the expression of adhesion molecules and proinflammatory cytokines in platelets and lung tissue. Therefore, HSYA is therapeutically effective for GEE-mediated lung injury and acts by enhancing PKA activity and inhibiting platelet activation | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a Gasoline engine exhaust | |
650 | 4 | |a Hydroxysafflor yellow A | |
650 | 4 | |a Lung dysfunction | |
650 | 4 | |a PKA | |
650 | 4 | |a Peroxisome proliferator-activated receptor γ | |
650 | 4 | |a Platelet | |
650 | 7 | |a Cytokines |2 NLM | |
650 | 7 | |a Gasoline |2 NLM | |
650 | 7 | |a PPAR gamma |2 NLM | |
650 | 7 | |a Plant Extracts |2 NLM | |
650 | 7 | |a Quinones |2 NLM | |
650 | 7 | |a Vehicle Emissions |2 NLM | |
650 | 7 | |a hydroxysafflor yellow A |2 NLM | |
650 | 7 | |a 146087-19-6 |2 NLM | |
650 | 7 | |a Chalcone |2 NLM | |
650 | 7 | |a 5S5A2Q39HX |2 NLM | |
650 | 7 | |a Cyclic AMP |2 NLM | |
650 | 7 | |a E0399OZS9N |2 NLM | |
650 | 7 | |a Cyclic AMP-Dependent Protein Kinases |2 NLM | |
650 | 7 | |a EC 2.7.11.11 |2 NLM | |
700 | 1 | |a Wang, Chunhua |e verfasserin |4 aut | |
700 | 1 | |a Ma, Chunlei |e verfasserin |4 aut | |
700 | 1 | |a Huang, Qingxian |e verfasserin |4 aut | |
700 | 1 | |a Sun, Hongliu |e verfasserin |4 aut | |
700 | 1 | |a Zhang, Xiaomin |e verfasserin |4 aut | |
700 | 1 | |a Bai, Xianyong |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Phytomedicine : international journal of phytotherapy and phytopharmacology |d 1994 |g 21(2014), 3 vom: 15. Feb., Seite 199-206 |w (DE-627)NLM093820402 |x 1618-095X |7 nnns |
773 | 1 | 8 | |g volume:21 |g year:2014 |g number:3 |g day:15 |g month:02 |g pages:199-206 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.phymed.2013.09.018 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 21 |j 2014 |e 3 |b 15 |c 02 |h 199-206 |